Skip to main content
Eligibility
for people ages 2 months and up
Location
at San Francisco, California and other locations
Dates
last updated December 1, 2016
Principal Investigator

Description

Summary

Provide patients with serious AdV infection or disease access to treatment with BCV.

Official Title

An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Keywords

Adenovirus Adenovirus Brincidofovir

Eligibility

You can join if…

Open to people ages 2 months and up

  • Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids
  • Able to swallow medication, either tablet or liquid

You CAN'T join if...

  • Previous dosing with Brincidofovir
  • If female, not pregnant or trying to become pregnant

Locations

  • Pediatric Stem Cell Transplantation Stanford University
    Palo Alto, California, 94304, United States
  • Children's Hospital LA
    Los Angeles, California, 90027, United States
  • UCLA Medical Center
    Los Angeles, California, 90095, United States
  • Children's Hospital of Orange County
    Orange, California, 92868, United States

Details

Status
not accepting new patients
Sponsor
Chimerix
ID
NCT02596997
Lead Scientist
Christopher Dvorak
Study Type
Expanded Access
Last Updated
December 1, 2016
I'm interested in this study!